|
1
|
Chen GC, Yu T, Min XH, Zhao LN, Qing Q,
Yuan YH, Su H, Zhan J, Huang KH and Chen QK: Prognosis of 153
patients with decompensated hepatitis B virus-related cirrhosis is
improved after 3-year continuous lamivudine treatment. Chin Med J
(Engl). 126:1538–1543. 2013.PubMed/NCBI
|
|
2
|
Lv GC, Yao JM, Yang YD, Zheng L, Sheng JF,
Chen Y and Li LJ: Efficacy of combined therapy in patients with
hepatitis B virus-related decompensated cirrhosis. World J
Gastroenterol. 19:3481–3486. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou YM, Zhang XF, Li B, Sui CJ and Yang
JM: Prognosis after resection of hepatitis B virus-related
hepatocellular carcinoma originating from non-cirrhotic liver. Ann
Surg Oncol. 21:2406–2412. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ming D, Yu X, Guo R, Deng Y, Li J, Lin C,
Su M, Lin Z and Su Z: Elevated TGF-β1/IL-31 pathway is associated
with the disease severity of hepatitis B virus-related liver
cirrhosis. Viral Immunol. 28:209–216. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun LL, Li YH, Chen F, Wang S and Shi H:
Study on correlation between liver ultrasonic appearance of
patients with chronic hepatitis B and cirrhosis and hydrothorax.
Eur Rev Med Pharmacol Sci. 20:50322016.PubMed/NCBI
|
|
6
|
Srivastava M, Rungta S, Dixit VK, Shukla
SK, Singh TB and Jain AK: Predictors of survival in hepatitis B
virus related decompensated cirrhosis on tenofovir therapy: An
Indian perspective. Antiviral Res. 100:300–305. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang N, Cao Y, Song W, He K, Li T, Wang J,
Xu B, Si HY, Hu CJ and Li AL: Serum peptide pattern that
differentially diagnoses hepatitis B virus-related hepatocellular
carcinoma from liver cirrhosis. J Gastroenterol Hepatol.
29:1544–1550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Öcal S, Korkmaz M, Harmancı Ö, Ensaroğlu
F, Akdur A, Selçuk H, Moray G and Haberal M: Hepatitis B- and
hepatitis D-virus-related liver transplant: Single-center data. Exp
Clin Transplant. 13 Suppl 1:133–138. 2015.PubMed/NCBI
|
|
9
|
Niro GA, Ippolito AM, Fontana R, Valvano
MR, Gioffreda D, Iacobellis A, Merla A, Durazzo M, Lotti G, Di
Mauro L, et al: Long-term outcome of hepatitis B virus-related
chronic hepatitis under protracted nucleos(t)ide analogues. J Viral
Hepat. 20:502–509. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu ZW, Lu HF, Wu J, Zuo J, Chen P, Sheng
JF, Zheng SS and Li LJ: Assessment of the fecal lactobacilli
population in patients with hepatitis B virus-related decompensated
cirrhosis and hepatitis B cirrhosis treated with liver transplant.
Microb Ecol. 63:929–937. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim IS, Mun JI, Koo JH, Kang CJ, Bak JK,
Cheong JY and Cho SW: Entecavir therapy for patients with hepatitis
B virus-related decompensated cirrhosis. Korean J Gastroenterol.
59:224–231. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z,
Wang JF, Zhang Z, Lu S, Huang X, et al: Plasma microRNA panel to
diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin
Oncol. 29:4781–4788. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun Y, Lu Y, Xie L, Deng Y, Li S and Qin
X: Interferon gamma polymorphisms and hepatitis B virus-related
liver cirrhosis risk in a Chinese population. Cancer Cell Int.
15:352015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Saichan X, Wei C, Qinglong F, Jun W and
Lei X: Plasma cortisol as a noninvasive biomarker to assess
severity and prognosis of patients with craniocerebral injury. Eur
Rev Med Pharmacol Sci. 20:3835–3838. 2016.PubMed/NCBI
|
|
15
|
Karra VK, Gumma PK, Chowdhury SJ, Ruttala
R, Polipalli SK, Chakravarti A and Kar P: IL-18 polymorphisms in
hepatitis B virus related liver disease. Cytokine. 73:277–282.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bae JS, Kim JH, Pasaje CF, Cheong HS, Lee
TH, Koh IS, Lee HS, Kim YJ and Shin HD: Association study of
genetic variations in microRNAs with the risk of hepatitis
B-related liver diseases. Dig Liver Dis. 44:849–854. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chu CM and Liaw YF: Hepatitis B
virus-related cirrhosis: Natural history and treatment. Semin Liver
Dis. 26:142–152. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hamrahian AH, Oseni TS and Arafah BM:
Measurements ofserum free cortisol in critically ill patients. N
EnglJ Med. 350:1629–1638. 2004. View Article : Google Scholar
|
|
19
|
Bárcena R, Domínguez-Antonaya M,
López-Sanromán A, Martínez-Turnes A, Urman J, del Campo S and
Moreno N: Lamivudine therapy of hepatitis B virus-related liver
disease: Cirrhosis, post-transplantation recurrence, and de novo
infection. Transplant Proc. 31:pp. 2457–2458. 1999; View Article : Google Scholar : PubMed/NCBI
|
